We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.29B
1-Year Est. Return 4.86%
This Fund
S&P 500
This Quarter Est. Return
+17.24%
1 Year Est. Return
-4.86%
3 Year Est. Return
+64.44%
5 Year Est. Return
+96.88%
10 Year Est. Return
+353.21%
AUM
$2.55B
AUM Growth
+$295M
Cap. Flow
-$14.8M
Cap. Flow %
-0.58%
Top 10 Hldgs %
65.49%
Holding
470
New
233
Increased
99
Reduced
73
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 49.05%
2 Consumer Discretionary 8.65%
3 Communication Services 8.21%
4 Utilities 6.88%
5 Technology 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOHO
376
DELISTED
Sotherly Hotels
SOHO
$34K ﹤0.01%
+13,679
New +$31.8K
SRI icon
377
Stoneridge
SRI
$205M
$34K ﹤0.01%
+1,650
New +$30.9K
KNL
378
DELISTED
Knoll, Inc.
KNL
$34K ﹤0.01%
+2,780
New +$30.6K
LAB icon
379
Standard BioTools
LAB
$271M
$33K ﹤0.01%
+8,210
New +$28.6K
PUK icon
380
Prudential
PUK
$32.7B
$33K ﹤0.01%
+1,113
New +$29.4K
MKSI icon
381
MKS Inc
MKSI
$15.7B
$32K ﹤0.01%
+285
New +$28.4K
OXY icon
382
Occidental Petroleum
OXY
$63.5B
$32K ﹤0.01%
1,730
PNR icon
383
Pentair
PNR
$9.03B
$31K ﹤0.01%
806
SCHW
384
Charles Schwab
SCHW
$186B
$31K ﹤0.01%
+908
New +$32.5K
SU icon
385
Suncor Energy
SU
$84.1B
$31K ﹤0.01%
+1,830
New +$31.3K
CRSP icon
386
CRISPR Therapeutics
CRSP
$5.01B
$30K ﹤0.01%
+413
New +$24.1K
GMAB icon
387
Genmab
GMAB
$21B
$30K ﹤0.01%
+880
New +$24K
RYAAY icon
388
Ryanair
RYAAY
$26.9B
$30K ﹤0.01%
+1,115
New +$28.2K
SPRO icon
389
Spero Therapeutics
SPRO
$65.8M
$30K ﹤0.01%
+2,215
New +$24.9K
CDTX
390
DELISTED
Cidara Therapeutics
CDTX
$29K ﹤0.01%
+387
New +$25.1K
JNCE
391
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$29K ﹤0.01%
+4,195
New +$22.6K
NTUS
392
DELISTED
Natus Medical Inc
NTUS
$29K ﹤0.01%
+1,340
New +$30.7K
APTV icon
393
Aptiv
APTV
$9.08B
$28K ﹤0.01%
+360
New +$24.8K
GE icon
394
GE Aerospace
GE
$319B
$28K ﹤0.01%
828
-65
-7% -$2.19K
BNY
395
Bank of New York Mellon
BNY
$105B
$27K ﹤0.01%
698
+3
+0.4% +$110
CNI icon
396
Canadian National Railway
CNI
$73.7B
$27K ﹤0.01%
+310
New +$25.8K
KRRO icon
397
Korro Bio
KRRO
$207M
$26K ﹤0.01%
+22
New +$19.9K
MDY icon
398
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
$26K ﹤0.01%
80
PXD
399
DELISTED
Pioneer Natural Resource Co.
PXD
$26K ﹤0.01%
+267
New +$23.5K
WUBA
400
DELISTED
58.com Inc
WUBA
$26K ﹤0.01%
+475
New +$24.5K

Similar funds

Bollard Group's Q2 2020 Portfolio in Review

As of Q2 2020, Bollard Group held 470 positions worth $2.55B, up 13% from $2.25B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Bollard Group's Q2 2020 filing shows 233 new, 99 increased, 73 reduced and 8 closed positions. Its largest new stake was DraftKings: 517,623 shares worth $17.2M. The largest sale was Shopify, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Bollard Group's largest Q2 2020 buy was DraftKings: 517,623 shares worth $17.2M.
  • Bollard Group added most to Gartner in Q2 2020, an estimated $22M increase.
  • Bollard Group's biggest Q2 2020 reduction was Shopify, cutting an estimated $17.9M.
  • Bollard Group fully exited Hasbro in Q2 2020, selling an estimated $545K.
  • Bollard Group's ten largest holdings make up 65% of its $2.55B portfolio in Q2 2020.
  • Bollard Group opened 233 new positions and closed 8 in Q2 2020.
  • Bollard Group's portfolio value rose 13% quarter-over-quarter to $2.55B.

Based on Bollard Group's 13F filing for Q2 2020, filed 13 Aug 2020.